Skip to main content
Watch Insiders

Corporate insider profile

Sandra Calvin Insider Trades

Latest reported as SVP, CHIEF ACCOUNTING OFFICER of Travere Therapeutics, Inc. (TVTX).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,237,599.79
Latest transaction
Sep 15, 2026

Affiliated corporations

Reported company relationships

TVTXLatest reported

Travere Therapeutics, Inc.

SVP, CHIEF ACCOUNTING OFFICER

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 15, 2026Travere Therapeutics, Inc. (TVTX)SVP, CHIEF ACCOUNTING OFFICERSale5,375$62.33$335,004
Apr 14, 2026Travere Therapeutics, Inc. (TVTX)SVP, CHIEF ACCOUNTING OFFICERSale21,977$41.07$902,595